Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fusidic acid + betamethasone cream vs Fucicort vs vehicle in infected eczema
2011-004370-28Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betamethasone + fusidic acid in atopic dermatitis (AD) (3 arms), sponsored by Dermapharm. Primary endpoint: Clinical treatment success at day 14. Started Mar 2012; status: completed.
02
Drugs
betamethasone + fusidic acid
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2011-004370-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004370-28.